Covid-19: Vaccine Production Debate
Full Debate: Read Full DebateLord Mackenzie of Framwellgate
Main Page: Lord Mackenzie of Framwellgate (Non-affiliated - Life peer)Department Debates - View all Lord Mackenzie of Framwellgate's debates with the Department for Business, Energy and Industrial Strategy
(3 years, 7 months ago)
Lords ChamberIt is not simply a question of scaling up untapped capacity; producing these vaccines is complicated and technically challenging, and we need the support of big pharma to do it. There are few facilities across the world that can produce them properly and we have seen, even in the West, how some batches have gone wrong because of manufacturing problems. However, we are proud to be working with the COVAX initiative. We have helped to raise more than £1 billion through match funding other donors. Combined with our aid, that is helping to distribute 1.8 billion doses across the world.
My Lords, AstraZeneca has been generous in providing vaccines to the world at cost. Do other companies oppose the principle of giving up their intellectual property rights in respect of these vaccines? As there is a humanitarian justification in their allowing the world to so benefit, would there be any merit in naming and shaming such big pharma companies?
It remains the case that we have not seen any convincing evidence that intellectual property is a limiting factor in the production and/or supply of Covid vaccines or other technologies. As the noble Lord points out, the Oxford/AstraZeneca vaccine is being made available at cost.